The evaluation of approaches to the treatment of myasthenia gravis.
Myasthenia gravis is a relatively rare autoimmune disease with an undetermined aetiology which affects neuromuscular junctions. Currently, the following approaches to the treatment of myasthenia gravis are mainly distinguished: symptomatic treatment with anticholinesterase inhibitors (AChEIs), immun...
Main Authors: | O. I. Kalbus, N. P. Shastun, S. O. Makarov, Yu. V. Bukreyeva, O. V. Somilo |
---|---|
Format: | Article |
Language: | English |
Published: |
SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine"
2019-11-01
|
Series: | Medičnì Perspektivi |
Subjects: | |
Online Access: | http://journals.uran.ua/index.php/2307-0404/article/view/181886 |
Similar Items
-
The miracle of St. Alfege’s Hospital and the history of the treatment of myasthenia gravis
by: Cristina Croitoru, et al.
Published: (2017-03-01) -
Management of Juvenile Myasthenia Gravis
by: Karen O'Connell, et al.
Published: (2020-07-01) -
Novel Treatments in Myasthenia Gravis
by: Deepak Menon, et al.
Published: (2020-06-01) -
Medical treatment for myasthenia gravis at a Myasthenia Center
by: Tatyana Valentinovna Romanova
Published: (2013-12-01) -
Management of myasthenia gravis during pregnancy: A report of eight cases
by: Shi Beibei, et al.
Published: (2018-04-01)